HS-101
/ HaplnScience
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 12, 2022
HaplnScience “Goal to enter phase 1 of osteoarthritis and chronic obstructive pulmonary disease next year” [Google translation]
(Hankyung)
- "Hapln Science is conducting non-clinical trials to apply for phase 1 clinical trials in the US for 'HS-101' (OA) and 'HS-401' (COPD), which are candidate substances derived based on these results. They plan to enter Phase 1 each next year."
New P1 trial • Preclinical • Chronic Obstructive Pulmonary Disease • CNS Disorders • Osteoarthritis • Pain
1 to 1
Of
1
Go to page
1